Alexander H. Staudacher PhD

Dr. Alex Staudacher is a Post-doctoral Research Scientist in the Translational Oncology Laboratory, Centre for Cancer Biology, University of South Australia and SA Pathology. Dr. Staudacher's work has focused on the dead-tumour cell-specific antibody APOMAB. This work includes radiolabeling the antibody with PET-emitting radionuclides for non-invasive PET imaging or labeling the antibody with beta-emitting or alpha-emitting radionuclides as a therapeutic in mouse tumour models. His work now focuses on whether ADCs of APOMAB could be effective in controlling tumour growth in pre-clinical cancer models.